NATIONAL RESEARCH
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer
Nilesh Gardi, Rohan Chaubal, Pallavi Para, Sunil Pachakar, Suyash Kulkarni, Tanuja Shet, Shalaka Joshi, Yogesh Kembhavi, Pratik Chandrani, Jelmar Quist, Pradnya Kowtal, Anita Grigoriadis, Rajiv Sarin, Raman Govindarajan, Sudeep Gupta (Corresponding Author)
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial
Sudeep Gupta, MD, DM, Nita Nair, DNB, MCh, Rohini W. Hawaldar, BSc, DCM, Shalaka Joshi, MS, MCh, MRes, Seema Gulia, MD, DM, Tanuja Shet, MD, Rajiv Sarin, MD, FRCR, Vani Parmar, MS, DNB, Sangeeta Desai, MD, DTM, Jaya Ghosh, MD, DM, Tabassum Wadasadawala, MD, DNB, Vaibhav Vanmali, BCom, PDCR, ADCSSAA, Tejal Panhale, BSc, PDCR, Pallavi Parab, BHMS, Asawari Patil, MD, Garvit Chitkara, DNB, Sushmita Rath, MD, DM, Jyoti Bajpai, MD, DM, Rima Pathak, MD, Palak Popat, DNB, Meenakshi Thakur, MD, and Rajendra A. Badwe, MS
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India
Anisha Mhatre1†Jinsha KorothJinsha Koroth1Meghana Manjunath,Meghana Manjunath1,2Sandeep Kumar SSandeep Kumar S3Ramesh GawariRamesh Gawari3Bibha Choudhary1*
Comprehensive Overview of Breast Cancer in India
Tryambak Pratap Srivastava, PhD, Isha Goel, PhD, Ajay Gogia, MD, Rajinder Parshad, MD, Sukhda Monga, MD, Joyeeta Talukdar, PhD, Avdhesh Rai, PhD, Ruby Dhar, PhD, and Subhradip Karmakar, PhD
Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns
Anisha Mhatre1†Jinsha KorothJinsha Koroth1Meghana Manjunath,Meghana Manjunath1,2Sandeep Kumar SSandeep Kumar S3Ramesh GawariRamesh Gawari3Bibha Choudhary1*
Synchronous and Metachronous Breast and Ovarian Cancers: Experience from a Single Tertiary Care Cancer Centre in India
Shalaka Joshi, Sridevi Murali-Nanavati, T. S. Shylasree, Rohini Hawaldar, Sagar Tripathi, Ayushi Sahay, Jarin Noronha, Urvashi Jain, Anand Thomas, Pradnya Kowtal, Vaibhav Vanmali, Nita S. Nair, Vani Parmar, Rajendra A. Badwe & Rajiv Sarin
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours
Arnab Ghosh, Rohan Chaubal, Chitrarpita Das, Pallavi Parab, Subrata Das, Arindam Maitra, Partha P. Majumder, Sudeep Gupta & Nidhan K. Biswas
Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population
Kunjal Lila Harshita Bhanushali MIlind Chanekar Raj Jatale Monisha Banerjee Rakhi Bajpai Dixit Aparna Rajadhyaksha Kirti Chadha
Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h-BRCA1
Neha Mishra, Suchita Dubey, Anchala Kumari, Mudassar Ali Khan, Ekaterina S. Kuligina, Elena V. Preobrazhenskaya, Alexandr A. Romanko, Lumbini R. Yadav, Rajiv Sarin
Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns
Anisha Mhatre1†Jinsha KorothJinsha Koroth1Meghana Manjunath,Meghana Manjunath1,2Sandeep Kumar SSandeep Kumar S3Ramesh GawariRamesh Gawari3Bibha Choudhary1*
Synchronous and Metachronous Breast and Ovarian Cancers: Experience from a Single Tertiary Care Cancer Centre in India
Shalaka Joshi, Sridevi Murali-Nanavati, T. S. Shylasree, Rohini Hawaldar, Sagar Tripathi, Ayushi Sahay, Jarin Noronha, Urvashi Jain, Anand Thomas, Pradnya Kowtal, Vaibhav Vanmali, Nita S. Nair, Vani Parmar, Rajendra A. Badwe & Rajiv Sarin
Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
Gupta S, Rajappa S, Advani S, Agarwal A, Aggarwal S, Goswami C, Palanki SD, Arya D, Patil S, Kodagali R
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations
Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Agarwal A, Sarin R, Ahmed R, Almel S, Chakraborti Bm et al.
Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening
Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A. et al.
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India
Molecular genetics analysis of hereditary breast and ovarian cancer patients in India
Soumittra N, Meenakumari B, Parija T, Sridevi V, Nancy KN, Swaminathan R, Rajalekshmy KR, Majhi U, Rajkumar T, et al
Spectrum of germline BRCA mutations in hereditary breast and ovarian cancer syndrome in Indian population
Chedda P, Pande S, Dama T, Vinarkar S, Chanekar M, Limaye S, et al
Genetic testing for hereditary breast and ovarian cancer in Indian population: A single institutional study.
Mutations in BRCA1/2 genes Unexpected higher prevalence in Indian Patients
Verma, Amit; Julka, Pramod Kumar; Kaur, Jatinder, et al